Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$652,895
+$76,264 QoQ
Shares Held
4,166
+10.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#775
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mutual Advisors, LLC holds $138,410,834 across 12 Drug Manufacturers - General names. NVS ranks #12 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
68,768 | $82,482,409 | |
| 2 | JNJ |
Johnson & Johnson
|
56,927 | $14,457,750 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,606 | $10,100,871 | |
| 4 | ABBV |
AbbVie Inc.
|
33,603 | $8,455,858 | |
| 5 | PFE |
Pfizer Inc
|
250,040 | $6,020,963 | |
| 6 | AMGN |
Amgen Inc
|
13,560 | $4,910,347 | |
| 7 | NVO |
Novo Nordisk A S
|
72,417 | $3,471,670 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,689 | $2,866,528 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $652,895 | 4,166 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $576,631 | 3,775 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $570,230 | 4,136 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $508,856 | 3,968 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $468,792 | 3,874 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $992,506 | 8,903 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $864,988 | 8,889 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,015,281 | 8,827 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,146,787 | 10,772 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,048,940 | 10,844 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $926,096 | 9,172 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $1,148,369 | 11,274 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,258,448 | 12,471 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $849,988 | 9,239 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $863,835 | 9,522 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $718,522 | 9,453 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $950,201 | 11,241 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,002,456 | 11,424 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,051,389 | 12,020 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $941,533 | 11,513 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $991,687 | 10,869 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $870,271 | 10,181 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,053,083 | 11,152 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,024,910 | 11,786 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,044,848 | 11,963 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $980,330 | 11,890 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||